| Year |
Citation |
Score |
| 2022 |
Manandhar P, Connor M, Santiago M. Tapentadol shows lower intrinsic efficacy at µ receptor than morphine and oxycodone. Pharmacology Research & Perspectives. 10: e00921. PMID 35084120 DOI: 10.1002/prp2.921 |
0.382 |
|
| 2021 |
Manandhar P, Murnion BP, Grimsey NL, Connor M, Santiago M. Do gabapentin or pregabalin directly modulate the µ receptor? Peerj. 9: e11175. PMID 33954038 DOI: 10.7717/peerj.11175 |
0.37 |
|
| 2020 |
Heblinski M, Santiago M, Fletcher C, Stuart J, Connor M, McGregor IS, Arnold JC. Terpenoids Commonly Found in Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels. Cannabis and Cannabinoid Research. 5: 305-317. PMID 33376801 DOI: 10.1089/can.2019.0099 |
0.318 |
|
| 2020 |
Gillis A, Gondin AB, Kliewer A, Sanchez J, Lim HD, Alamein C, Manandhar P, Santiago M, Fritzwanker S, Schmidel F, Katte TA, Reekie T, Grimsey NL, Kassiou M, Kellam B, ... ... Connor M, et al. Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Science Signaling. 13. PMID 32234959 DOI: 10.1126/Scisignal.Aaz3140 |
0.694 |
|
| 2020 |
Sachdev S, Banister SD, Santiago M, Bladen C, Kassiou M, Connor M. Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists. Pharmacology Research & Perspectives. 8: e00566. PMID 32101383 DOI: 10.1002/prp2.566 |
0.383 |
|
| 2019 |
Sachdev S, Boyd R, Grimsey NL, Santiago M, Connor M. Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells. Peerj. 7: e7733. PMID 31579608 DOI: 10.7717/peerj.7733 |
0.366 |
|
| 2019 |
Sachdev S, Vemuri K, Banister SD, Longworth M, Kassiou M, Santiago M, Makriyannis A, Connor M. In vitro determination of the CB1 efficacy of illicit synthetic cannabinoids. British Journal of Pharmacology. PMID 31412133 DOI: 10.1111/Bph.14829 |
0.38 |
|
| 2019 |
Udoh M, Santiago M, Devenish S, McGregor IS, Connor M. Cannabichromene is a cannabinoid CB2 receptor agonist. British Journal of Pharmacology. PMID 31368508 DOI: 10.1111/bph.14815 |
0.399 |
|
| 2019 |
Moir M, Lane S, Lai F, Connor M, Hibbs DE, Kassiou M. Strategies to develop selective CB receptor agonists from indole carboxamide synthetic cannabinoids. European Journal of Medicinal Chemistry. 180: 291-309. PMID 31319265 DOI: 10.1016/j.ejmech.2019.07.036 |
0.405 |
|
| 2019 |
Kevin RC, Anderson L, McGregor IS, Boyd R, Manning JJ, Glass M, Connor M, Banister SD. CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist. Frontiers in Pharmacology. 10: 595. PMID 31191320 DOI: 10.3389/fphar.2019.00595 |
0.426 |
|
| 2019 |
Banister SD, Arnold JC, Connor M, Glass M, McGregor IS. Dark Classics in Chemical Neuroscience: Δ-Tetrahydrocannabinol. Acs Chemical Neuroscience. PMID 30689342 DOI: 10.1021/acschemneuro.8b00651 |
0.314 |
|
| 2019 |
Borsodi A, Bruchas M, Caló G, Chavkin C, Christie MJ, Civelli O, Connor M, Cox BM, Devi LA, Evans C, Höllt V, Henderson G, Husbands S, Kelly E, Kieffer B, et al. Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f50/2019.4 |
0.807 |
|
| 2019 |
Moir M, Boyd R, Gunosewoyo H, Montgomery AP, Connor M, Kassiou M. Synthesis and evaluation of various heteroaromatic benzamides as analogues of –ylidene-benzamide cannabinoid type 2 receptor agonists Tetrahedron Letters. 60: 151019. DOI: 10.1016/J.TETLET.2019.151019 |
0.392 |
|
| 2019 |
Longworth M, Reekie TA, Blakey K, Boyd R, Connor M, Kassiou M. New-generation azaindole-adamantyl-derived synthetic cannabinoids Forensic Toxicology. 37: 350-365. DOI: 10.1007/s11419-019-00466-1 |
0.332 |
|
| 2018 |
Heblinski M, Bladen C, Connor M. Regulation of heterologously expressed 5-HT receptors coupling to K channels in AtT-20 cells. British Journal of Pharmacology. PMID 30447001 DOI: 10.1111/bph.14547 |
0.357 |
|
| 2018 |
Banister SD, Connor M. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution. Handbook of Experimental Pharmacology. PMID 30105473 DOI: 10.1007/164_2018_144 |
0.325 |
|
| 2018 |
Banister SD, Olson A, Winchester M, Stuart J, Edington AR, Kevin RC, Longworth M, Herrera M, Connor M, McGregor IS, Gerona RR, Kassiou M. The chemistry and pharmacology of synthetic cannabinoid SDB-006 and its regioisomeric fluorinated and methoxylated analogues. Drug Testing and Analysis. PMID 29350472 DOI: 10.1002/Dta.2362 |
0.308 |
|
| 2017 |
Jorgensen WT, Gulliver DW, Katte TA, Werry EL, Reekie TA, Connor M, Kassiou M. Conformationally rigid derivatives of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin-1a receptors. European Journal of Medicinal Chemistry. PMID 29126725 DOI: 10.1016/j.ejmech.2017.10.059 |
0.316 |
|
| 2017 |
Longworth M, Banister SD, Boyd R, Kevin RC, Connor M, McGregor IS, Kassiou M. Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues. Acs Chemical Neuroscience. PMID 28792725 DOI: 10.1021/acschemneuro.7b00267 |
0.3 |
|
| 2017 |
Bokiniec P, Shahbazian S, McDougall SJ, Berning BA, Cheng D, Llewellyn-Smith IJ, Burke PG, McMullan S, Mühlenhoff M, Hildebrandt H, Braet F, Connor M, Packer NH, Goodchild AK. Polysialic acid regulates sympathetic outflow by facilitating information transfer within the nucleus of the solitary tract. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28576943 DOI: 10.1523/Jneurosci.0200-17.2017 |
0.335 |
|
| 2017 |
Longworth M, Connor M, Banister SD, Kassiou M. Synthesis and Pharmacological profiling of the metabolites of synthetic cannabinoid drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA. Acs Chemical Neuroscience. PMID 28574245 DOI: 10.1021/acschemneuro.7b00116 |
0.311 |
|
| 2017 |
Katte TA, Reekie TA, Werry EL, Jorgensen WT, Boyd R, Wong ECN, Gulliver DW, Connor M, Kassiou M. Investigation of pyrazolo-sulfonamides as putative small molecule oxytocin receptor agonists. European Journal of Medicinal Chemistry. 136: 330-333. PMID 28505537 DOI: 10.1016/j.ejmech.2017.05.013 |
0.4 |
|
| 2017 |
Chatchaisak D, Connor M, Srikiatkhachorn A, Chetsawang B. The potentiating effect of calcitonin gene-related peptide on transient receptor potential vanilloid-1 activity and the electrophysiological responses of rat trigeminal neurons to nociceptive stimuli. The Journal of Physiological Sciences : Jps. PMID 28205139 DOI: 10.1007/s12576-017-0529-9 |
0.422 |
|
| 2017 |
Soethoudt M, Grether U, Fingerle J, Grim TW, Fezza F, de Petrocellis L, Ullmer C, Rothenhäusler B, Perret C, van Gils N, Finlay D, MacDonald C, Chicca A, Gens MD, Stuart J, ... ... Connor M, et al. Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity. Nature Communications. 8: 13958. PMID 28045021 DOI: 10.1038/Ncomms13958 |
0.322 |
|
| 2016 |
Banister SD, Longworth M, Kevin R, Sachdev S, Santiago M, Stuart J, Mack JB, Glass M, McGregor IS, Connor M, Kassiou M. The pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues. Acs Chemical Neuroscience. PMID 27421060 DOI: 10.1021/acschemneuro.6b00137 |
0.303 |
|
| 2015 |
Jorgensen WT, Gulliver DW, Werry EL, Reekie T, Connor M, Kassiou M. Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1a receptors. European Journal of Medicinal Chemistry. 108: 730-740. PMID 26741855 DOI: 10.1016/j.ejmech.2015.11.050 |
0.409 |
|
| 2015 |
Cawston EE, Connor M, Di Marzo V, Silvestri R, Glass M. Distinct Temporal Fingerprint for Cyclic Adenosine Monophosphate (cAMP) Signaling of Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid Receptors. Journal of Medicinal Chemistry. 58: 5979-88. PMID 26203658 DOI: 10.1021/acs.jmedchem.5b00579 |
0.346 |
|
| 2015 |
Banister SD, Moir M, Stuart J, Kevin RC, Wood KE, Longworth M, Wilkinson SM, Beinat C, Buchanan AS, Glass M, Connor M, McGregor IS, Kassiou M. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. Acs Chemical Neuroscience. PMID 26134475 DOI: 10.1021/acschemneuro.5b00112 |
0.309 |
|
| 2015 |
Banister SD, Stuart J, Kevin RC, Edington A, Longworth M, Wilkinson SM, Beinat C, Buchanan AS, Hibbs DE, Glass M, Connor M, McGregor IS, Kassiou M. Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. Acs Chemical Neuroscience. PMID 25921407 DOI: 10.1021/acschemneuro.5b00107 |
0.363 |
|
| 2015 |
Christie MJ, Connor M, Traynor JR. Themed section. British Journal of Pharmacology. 172: 247-50. PMID 25537825 DOI: 10.1111/bph.13028 |
0.565 |
|
| 2015 |
Knapman A, Santiago M, Connor M. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro. British Journal of Pharmacology. 172: 2258-72. PMID 25521224 DOI: 10.1111/bph.13047 |
0.444 |
|
| 2015 |
Knapman A, Connor M. Fluorescence-based, high-throughput assays for μ-opioid receptor activation using a membrane potential-sensitive dye. Methods in Molecular Biology (Clifton, N.J.). 1230: 177-85. PMID 25293325 DOI: 10.1007/978-1-4939-1708-2_14 |
0.462 |
|
| 2015 |
Connor M, Bagley EE, Chieng BC, Christie MJ. β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons. British Journal of Pharmacology. 172: 492-500. PMID 24597632 DOI: 10.1111/bph.12673 |
0.703 |
|
| 2015 |
Knapman A, Connor M. Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1). British Journal of Pharmacology. 172: 349-63. PMID 24527749 DOI: 10.1111/bph.12644 |
0.467 |
|
| 2015 |
Banister SD, Stuart J, Conroy T, Longworth M, Manohar M, Beinat C, Wilkinson SM, Kevin RC, Hibbs DE, Glass M, Connor M, McGregor IS, Kassiou M. Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues Forensic Toxicology. 33: 355-366. DOI: 10.1007/s11419-015-0282-9 |
0.328 |
|
| 2014 |
Redmond WJ, Camo M, Mitchell V, Vaughan CW, Connor M. Nordihydroguaiaretic acid activates hTRPA1 and modulates behavioral responses to noxious cold in mice. Pharmacology Research & Perspectives. 2: e00079. PMID 25505619 DOI: 10.1002/prp2.79 |
0.656 |
|
| 2014 |
Knapman A, Santiago M, Connor M. Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro. British Journal of Pharmacology. 171: 4273-88. PMID 24846673 DOI: 10.1111/bph.12785 |
0.478 |
|
| 2014 |
Redmond WJ, Gu L, Camo M, McIntyre P, Connor M. Ligand determinants of fatty acid activation of the pronociceptive ion channel TRPA1. Peerj. 2: e248. PMID 24516781 DOI: 10.7717/peerj.248 |
0.323 |
|
| 2014 |
Knapman A, Abogadie F, McIntrye P, Connor M. A real-time, fluorescence-based assay for measuring μ-opioid receptor modulation of adenylyl cyclase activity in Chinese hamster ovary cells. Journal of Biomolecular Screening. 19: 223-31. PMID 23989451 DOI: 10.1177/1087057113501391 |
0.44 |
|
| 2013 |
Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, Catterall WA, Spedding M, Peters JA, Harmar AJ, Abul-Hasn N, Anderson CM, Anderson CM, Araiksinen MS, ... ... Connor MA, et al. The Concise Guide to PHARMACOLOGY 2013/14: overview. British Journal of Pharmacology. 170: 1449-58. PMID 24528237 DOI: 10.1111/Bph.12444 |
0.498 |
|
| 2013 |
Cawston EE, Redmond WJ, Breen CM, Grimsey NL, Connor M, Glass M. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action. British Journal of Pharmacology. 170: 893-907. PMID 23937487 DOI: 10.1111/bph.12329 |
0.402 |
|
| 2013 |
Banister SD, Wilkinson SM, Longworth M, Stuart J, Apetz N, English K, Brooker L, Goebel C, Hibbs DE, Glass M, Connor M, McGregor IS, Kassiou M. The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse. Acs Chemical Neuroscience. 4: 1081-92. PMID 23551277 DOI: 10.1021/cn400035r |
0.339 |
|
| 2013 |
Knapman A, Santiago M, Du YP, Bennallack PR, Christie MJ, Connor M. A continuous, fluorescence-based assay of μ-opioid receptor activation in AtT-20 cells. Journal of Biomolecular Screening. 18: 269-76. PMID 23015017 DOI: 10.1177/1087057112461376 |
0.721 |
|
| 2012 |
Sreenivasan VK, Kim EJ, Goodchild AK, Connor M, Zvyagin AV. Targeting somatostatin receptors using in situ-bioconjugated fluorescent nanoparticles. Nanomedicine (London, England). 7: 1551-60. PMID 22812712 DOI: 10.2217/Nnm.12.42 |
0.333 |
|
| 2012 |
Gilmore AJ, Heblinski M, Reynolds A, Kassiou M, Connor M. Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT. British Journal of Pharmacology. 167: 1076-88. PMID 22624680 DOI: 10.1111/j.1476-5381.2012.02047.x |
0.328 |
|
| 2011 |
Fioretti B, Catacuzzeno L, Sforna L, Gerke-Duncan MB, van den Maagdenberg AM, Franciolini F, Connor M, Pietrobon D. Trigeminal ganglion neuron subtype-specific alterations of Ca(V)2.1 calcium current and excitability in a Cacna1a mouse model of migraine. The Journal of Physiology. 589: 5879-95. PMID 22005682 DOI: 10.1113/jphysiol.2011.220533 |
0.375 |
|
| 2011 |
Sreenivasan VK, Stremovskiy OA, Kelf TA, Heblinski M, Goodchild AK, Connor M, Deyev SM, Zvyagin AV. Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist. Bioconjugate Chemistry. 22: 1768-75. PMID 21823634 DOI: 10.1021/Bc200104U |
0.395 |
|
| 2010 |
Connor M, Traynor J. Constitutively active μ-opioid receptors. Methods in Enzymology. 484: 445-69. PMID 21036245 DOI: 10.1016/B978-0-12-381298-8.00022-8 |
0.503 |
|
| 2010 |
Connor M, Vaughan CW, Vandenberg RJ. N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets. British Journal of Pharmacology. 160: 1857-71. PMID 20649585 DOI: 10.1111/J.1476-5381.2010.00862.X |
0.321 |
|
| 2009 |
Connor M. Shadows across mu-Star? Constitutively active mu-opioid receptors revisited. British Journal of Pharmacology. 156: 1041-3. PMID 19368530 DOI: 10.1111/j.1476-5381.2009.00067.x |
0.508 |
|
| 2009 |
Ross HR, Gilmore AJ, Connor M. Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine. British Journal of Pharmacology. 156: 740-50. PMID 19226289 DOI: 10.1111/j.1476-5381.2008.00072.x |
0.369 |
|
| 2008 |
Jeong HJ, Chenu D, Johnson EE, Connor M, Vaughan CW. Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Molecular Pain. 4: 54. PMID 19014464 DOI: 10.1186/1744-8069-4-54 |
0.683 |
|
| 2008 |
Ross HR, Napier I, Connor M. Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol. The Journal of Biological Chemistry. 283: 16124-34. PMID 18390906 DOI: 10.1074/jbc.M707104200 |
0.382 |
|
| 2008 |
Roberts LA, Ross HR, Connor M. Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. Neuropharmacology. 54: 172-80. PMID 17631916 DOI: 10.1016/j.neuropharm.2007.05.024 |
0.617 |
|
| 2007 |
Johnson EE, Connor M. Towards a receptor for nocistatin? British Journal of Pharmacology. 152: 415-6. PMID 17618302 DOI: 10.1038/sj.bjp.0707384 |
0.408 |
|
| 2006 |
Roberts LA, Connor M. TRPV1 antagonists as a potential treatment for hyperalgesia. Recent Patents On Cns Drug Discovery. 1: 65-76. PMID 18221192 DOI: 10.2174/157488906775245309 |
0.539 |
|
| 2006 |
Johnson EE, Chieng B, Napier I, Connor M. Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice. British Journal of Pharmacology. 148: 947-55. PMID 16783402 DOI: 10.1038/sj.bjp.0706820 |
0.527 |
|
| 2006 |
Connor M, Kitchen I. Has the sun set on kappa3-opioid receptors? British Journal of Pharmacology. 147: 349-50. PMID 16402044 DOI: 10.1038/Sj.Bjp.0706603 |
0.508 |
|
| 2006 |
Yung W, Johnson EE, Christie MJ, Connor M, Yao X, Kwan H, Huang Y, Yung WH, Lui PW, Yeung CW, Shi Y, Chen LW, Chan YS, Yung KKL, Ioja E, et al. Subject Index Vol. 14, 2005 Neurosignals. 14: 330-330. DOI: 10.1159/000093977 |
0.567 |
|
| 2005 |
Johnson EE, Christie MJ, Connor M. The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment. Neuro-Signals. 14: 290-302. PMID 16772732 DOI: 10.1159/000093044 |
0.73 |
|
| 2005 |
Connor M, Naves LA, McCleskey EW. Contrasting phenotypes of putative proprioceptive and nociceptive trigeminal neurons innervating jaw muscle in rat. Molecular Pain. 1: 31. PMID 16242047 DOI: 10.1186/1744-8069-1-31 |
0.351 |
|
| 2005 |
Bagley EE, Chieng BC, Christie MJ, Connor M. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. British Journal of Pharmacology. 146: 68-76. PMID 15980868 DOI: 10.1038/sj.bjp.0706315 |
0.743 |
|
| 2005 |
Marinelli S, Connor M, Schnell SA, Christie MJ, Wessendorf MW, Vaughan CW. delta-opioid receptor-mediated actions on rostral ventromedial medulla neurons. Neuroscience. 132: 239-44. PMID 15802178 DOI: 10.1016/j.neuroscience.2005.01.015 |
0.743 |
|
| 2005 |
Connor M, Vaughan CW. Humanizing mice: catching up with elusive B1 receptors. British Journal of Pharmacology. 144: 885-6. PMID 15685198 DOI: 10.1038/sj.bjp.0706141 |
0.649 |
|
| 2005 |
Bailey CP, Connor M. Opioids: cellular mechanisms of tolerance and physical dependence. Current Opinion in Pharmacology. 5: 60-8. PMID 15661627 DOI: 10.1016/j.coph.2004.08.012 |
0.342 |
|
| 2005 |
Yung W, Johnson EE, Christie MJ, Connor M, Yao X, Kwan H, Huang Y, Yung WH, Lui PW, Yeung CW, Shi Y, Chen LW, Chan YS, Yung KKL, Ioja E, et al. Contents Vol. 14, 2005 Neurosignals. 14: 331-332. DOI: 10.1159/000093978 |
0.563 |
|
| 2004 |
Connor M, Osborne PB, Christie MJ. Mu-opioid receptor desensitization: is morphine different? British Journal of Pharmacology. 143: 685-96. PMID 15504746 DOI: 10.1038/sj.bjp.0705938 |
0.73 |
|
| 2004 |
Connor M, Bagley EE, Mitchell VA, Ingram SL, Christie MJ, Humphrey PP, Vaughan CW. Cellular actions of somatostatin on rat periaqueductal grey neurons in vitro. British Journal of Pharmacology. 142: 1273-80. PMID 15265812 DOI: 10.1038/Sj.Bjp.0705894 |
0.814 |
|
| 2003 |
Vaughan CW, Connor M. In search of a role for the morphine metabolite morphine-3-glucuronide. Anesthesia and Analgesia. 97: 311-2. PMID 12873910 DOI: 10.1213/01.Ane.0000078220.83604.7E |
0.483 |
|
| 2003 |
Chebib M, Duke RK, Duke CC, Connor M, Mewett KN, Johnston GA. Convulsant actions of calycanthine. Toxicology and Applied Pharmacology. 190: 58-64. PMID 12831783 DOI: 10.1016/S0041-008X(03)00149-2 |
0.363 |
|
| 2003 |
Borgland SL, Connor M, Osborne PB, Furness JB, Christie MJ. Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors. The Journal of Biological Chemistry. 278: 18776-84. PMID 12642578 DOI: 10.1074/Jbc.M300525200 |
0.818 |
|
| 2002 |
Dedov VN, Tran VH, Duke CC, Connor M, Christie MJ, Mandadi S, Roufogalis BD. Gingerols: a novel class of vanilloid receptor (VR1) agonists. British Journal of Pharmacology. 137: 793-8. PMID 12411409 DOI: 10.1038/sj.bjp.0704925 |
0.717 |
|
| 2002 |
Roberts LA, Christie MJ, Connor M. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. British Journal of Pharmacology. 137: 421-8. PMID 12359623 DOI: 10.1038/sj.bjp.0704904 |
0.724 |
|
| 2002 |
Marinelli S, Vaughan CW, Christie MJ, Connor M. Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. The Journal of Physiology. 543: 531-40. PMID 12205187 DOI: 10.1113/jphysiol.2002.022863 |
0.793 |
|
| 2002 |
Borgland SL, Connor M, Ryan RM, Ball HJ, Christie MJ. Prostaglandin E(2) inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. The Journal of Physiology. 539: 433-44. PMID 11882676 DOI: 10.1113/Jphysiol.2001.013322 |
0.808 |
|
| 2001 |
Borgland SL, Connor M, Christie MJ. Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. The Journal of Physiology. 536: 35-47. PMID 11579155 DOI: 10.1111/j.1469-7793.2001.t01-1-00035.x |
0.809 |
|
| 2001 |
Wang XH, Connor M, Wilson D, Wilson HI, Nicholson GM, Smith R, Shaw D, Mackay JP, Alewood PF, Christie MJ, King GF. Discovery and structure of a potent and highly specific blocker of insect calcium channels. The Journal of Biological Chemistry. 276: 40306-12. PMID 11522785 DOI: 10.1074/Jbc.M105206200 |
0.639 |
|
| 2001 |
Vaughan CW, Connor M, Jennings EA, Marinelli S, Allen RG, Christie MJ. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro. The Journal of Physiology. 534: 849-59. PMID 11483714 DOI: 10.1111/j.1469-7793.2001.00849.x |
0.752 |
|
| 2000 |
Wang X, Connor M, Smith R, Maciejewski MW, Howden ME, Nicholson GM, Christie MJ, King GF. Discovery and characterization of a family of insecticidal neurotoxins with a rare vicinal disulfide bridge. Nature Structural Biology. 7: 505-13. PMID 10881200 DOI: 10.1038/75921 |
0.607 |
|
| 2000 |
Christie MJ, Connor M, Vaughan CW, Ingram SL, Bagley EE. Cellular actions of opioids and other analgesics: implications for synergism in pain relief. Clinical and Experimental Pharmacology & Physiology. 27: 520-3. PMID 10874510 DOI: 10.1046/J.1440-1681.2000.03291.X |
0.814 |
|
| 2000 |
Szeto TH, Birinyi-Strachan LC, Smith R, Connor M, Christie MJ, King GF, Nicholson GM. Isolation and pharmacological characterisation of delta-atracotoxin-Hv1b, a vertebrate-selective sodium channel toxin. Febs Letters. 470: 293-9. PMID 10745084 DOI: 10.1016/S0014-5793(00)01339-9 |
0.674 |
|
| 2000 |
Szeto TH, Wang XH, Smith R, Connor M, Christie MJ, Nicholson GM, King GF. Isolation of a funnel-web spider polypeptide with homology to mamba intestinal toxin 1 and the embryonic head inducer Dickkopf-1. Toxicon : Official Journal of the International Society On Toxinology. 38: 429-42. PMID 10669030 DOI: 10.1016/S0041-0101(99)00174-9 |
0.615 |
|
| 2000 |
Vaughan CW, Connor M, Bagley EE, Christie MJ. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Molecular Pharmacology. 57: 288-95. PMID 10648638 |
0.725 |
|
| 1999 |
Connor M, Borgland SL, Christie MJ. Continued morphine modulation of calcium channel currents in acutely isolated locus coeruleus neurons from morphine-dependent rats. British Journal of Pharmacology. 128: 1561-9. PMID 10602337 DOI: 10.1038/sj.bjp.0702922 |
0.819 |
|
| 1999 |
Connor M, Vaughan CW, Jennings EA, Allen RG, Christie MJ. Nociceptin, Phe(1)psi-nociceptin(1 - 13), nocistatin and prepronociceptin(154 - 181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro. British Journal of Pharmacology. 128: 1779-87. PMID 10588934 DOI: 10.1038/sj.bjp.0702971 |
0.71 |
|
| 1999 |
Fletcher JI, Dingley AJ, Smith R, Connor M, Christie MJ, King GF. High-resolution solution structure of gurmarin, a sweet-taste-suppressing plant polypeptide. European Journal of Biochemistry / Febs. 264: 525-33. PMID 10491100 DOI: 10.1046/J.1432-1327.1999.00659.X |
0.626 |
|
| 1999 |
Connor M, Christie MD. Opioid receptor signalling mechanisms. Clinical and Experimental Pharmacology & Physiology. 26: 493-9. PMID 10405772 DOI: 10.1046/j.1440-1681.1999.03049.x |
0.489 |
|
| 1999 |
Connor M, Schuller A, Pintar JE, Christie MJ. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. British Journal of Pharmacology. 126: 1553-8. PMID 10323586 DOI: 10.1038/sj.bjp.0702457 |
0.76 |
|
| 1999 |
Fletcher JI, Wang X, Connor M, Christie MJ, King GF, Nicholson GM. Spider toxins: A new group of potassium channel modulators Perspectives in Drug Discovery and Design. 15: 61-69. DOI: 10.1023/A:1017039418046 |
0.628 |
|
| 1998 |
Ingram SL, Vaughan CW, Bagley EE, Connor M, Christie MJ. Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 10269-76. PMID 9852564 DOI: 10.1523/Jneurosci.18-24-10269.1998 |
0.799 |
|
| 1998 |
Little MJ, Zappia C, Gilles N, Connor M, Tyler MI, Martin-Eauclaire MF, Gordon D, Nicholson GM. delta-Atracotoxins from australian funnel-web spiders compete with scorpion alpha-toxin binding but differentially modulate alkaloid toxin activation of voltage-gated sodium channels. The Journal of Biological Chemistry. 273: 27076-83. PMID 9765223 DOI: 10.1074/jbc.273.42.27076 |
0.367 |
|
| 1998 |
Connor M, Christie MJ. Modulation of Ca2+ channel currents of acutely dissociated rat periaqueductal grey neurons. The Journal of Physiology. 509: 47-58. PMID 9547380 DOI: 10.1111/j.1469-7793.1998.047bo.x |
0.757 |
|
| 1997 |
Harrison PK, Connor M, Kelly E. Chronic ethanol promotes the neuronal differentiation of NG108-15 cells independently of toxin-sensitive G-proteins. Environmental Toxicology and Pharmacology. 3: 307-19. PMID 21781791 DOI: 10.1016/S1382-6689(97)00023-9 |
0.325 |
|
| 1997 |
Connor M, Ingram SL, Christie MJ. Cortistatin increase of a potassium conductance in rat locus coeruleus in vitro. British Journal of Pharmacology. 122: 1567-72. PMID 9422800 DOI: 10.1038/Sj.Bjp.0701541 |
0.779 |
|
| 1997 |
Vaughan CW, Ingram SL, Connor MA, Christie MJ. How opioids inhibit GABA-mediated neurotransmission. Nature. 390: 611-4. PMID 9403690 DOI: 10.1038/37610 |
0.785 |
|
| 1997 |
Fletcher JI, Smith R, O'Donoghue SI, Nilges M, Connor M, Howden ME, Christie MJ, King GF. The structure of a novel insecticidal neurotoxin, omega-atracotoxin-HV1, from the venom of an Australian funnel web spider. Nature Structural Biology. 4: 559-66. PMID 9228949 DOI: 10.1038/Nsb0797-559 |
0.636 |
|
| 1997 |
Connor MA, Keir MJ, Henderson G. delta-opioid receptor mobilization of intracellular calcium in SH-SY5Y cells: lack of evidence for delta-receptor subtypes. Neuropharmacology. 36: 125-33. PMID 9144649 DOI: 10.1016/S0028-3908(96)00144-X |
0.563 |
|
| 1997 |
Connor M, Henderson G. Bradykinin inhibition of N- and L-type calcium channel currents in NG108-15 cells. Neuropharmacology. 36: 115-24. PMID 9144648 DOI: 10.1016/S0028-3908(96)00145-1 |
0.532 |
|
| 1997 |
Connor M, Yeo A, Henderson G. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. British Journal of Pharmacology. 120: 455-63. PMID 9031749 DOI: 10.1038/sj.bjp.0700920 |
0.544 |
|
| 1996 |
Connor M, Vaughan CW, Chieng B, Christie MJ. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. British Journal of Pharmacology. 119: 1614-8. PMID 8982509 DOI: 10.1111/J.1476-5381.1996.Tb16080.X |
0.748 |
|
| 1996 |
Chieng B, Connor M, Christie MJ. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons. Molecular Pharmacology. 50: 650-5. PMID 8794906 |
0.721 |
|
| 1996 |
Connor M, Henderson G. delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. British Journal of Pharmacology. 117: 333-40. PMID 8789387 DOI: 10.1111/j.1476-5381.1996.tb15195.x |
0.584 |
|
| 1996 |
Connor M, Yeo A, Henderson G. The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line. British Journal of Pharmacology. 118: 205-7. PMID 8735615 DOI: 10.1111/J.1476-5381.1996.Tb15387.X |
0.619 |
|
| 1995 |
Connor MA, Grudt TJ, Henderson G. THE INTERACTION BETWEEN OPIOID AND MUSCARINIC RECEPTORS IN THE MOBILIZATION OF INTRACELLULAR CALCIUM IN SH-SY5Y CELLS Analgesia. 1: 371-374. DOI: 10.3727/107156995819563898 |
0.545 |
|
| 1995 |
Connor MA, Keir MJ, Henderson G. δ-OPIOJD RECEPTOR MOBILIZATION OF INTRACELLULAR CALCIUM IN SH-SY5Y CELLS: LACK OF EVIDENCE FOR 8 RECEPTOR SUBTYPES Analgesia. 1: 375-378. DOI: 10.3727/107156995819563186 |
0.493 |
|
| 1994 |
Patterson TA, Connor M, Appleyard SM, Chavkin C. Oocytes from Xenopus laevis contain an intrinsic sigma 2-like binding site. Neuroscience Letters. 180: 159-62. PMID 7700571 DOI: 10.1016/0304-3940(94)90511-8 |
0.714 |
|
| 1994 |
Connor M, Planner A, Henderson G. δ and μ opioid receptor mobilization of intracellular calcium in neuroblastoma cells Regulatory Peptides. 54: 65-66. DOI: 10.1016/0167-0115(94)90391-3 |
0.599 |
|
| 1992 |
Connor MA, Chavkin C. Ionic zinc may function as an endogenous ligand for the haloperidol-sensitive sigma 2 receptor in rat brain. Molecular Pharmacology. 42: 471-9. PMID 1406599 |
0.492 |
|
| 1991 |
Connor MA, Chavkin C. Focal stimulation of specific pathways in the rat hippocampus causes a reduction in radioligand binding to the haloperidol-sensitive sigma receptor. Experimental Brain Research. 85: 528-36. PMID 1680737 DOI: 10.1007/BF00231736 |
0.489 |
|
| Show low-probability matches. |